Revision as of 22:41, 19 November 2015

Week 10

• On November 3, 2015, GÉNialOMICS chose to create database for Burkholderia cenocepacia.
• On November 5, 2015, a journal detailing the complete genome of Burkholderia cenocepacia (strain J2315) titled The Genome of Burkholderia cenocepacia J2315, an Epidemic Pathogen of Cystic Fibrosis Patients was found.

Week 11

Individual Goals and Progress

File Management System

• Files utilized in weekly projects will renamed as follows: XXXX_GEN_(Initials)(Week#)_yyyymmdd, where "XXXX" is the original filename. If multiple versions of the same file (with identical filenames) are used on the same day then a (positive integer) (starting from 1) will be added to any additional versions (e.g. XXXX_GEN_BL11_yyyymmdd, XXXX_GEN_BL11_yyyymmdd(1), XXXX_GEN_BL11_yyyymmdd(2), for three different versions of the same file uploaded by Brandon Litvak during Week 11)
• Files will be uploaded to the weekly progress table under a file row with a clear label (under the respective group member that created them/used them)
• All original unmodified files will be saved and will also be uploaded, together, as a compressed zip with the filename: ORIG_GEN_(Initials)(Week#); the compressed zip containing all original files will be the last entry in the row designated for the files, with the label "ORIGINAL FILES"

Other Progress

• A journal using the B. cenocepacia genome in a microarray experiment titled Biofilm-Grown Burkholderia cepacia Complex Cells Survive Antibiotic Treatment by Avoiding Production of Reactive Oxygen Species was approved for analysis.

Journal Club Presentations

Genome Paper Presentation Week 11
Microarray Paper Presentation Week 12

Week 12

Individual Goals and Progress

Other Progress

Burkholderia cenocepacia Genome Paper

Holden, M. T. G., Seth-Smith, H. M. B., Crossman, L. C., Sebaihia, M., Bentley, S. D., Cerdeño-Tárraga, A. M., … Parkhill, J. (2009). The Genome of Burkholderia cenocepacia J2315, an Epidemic Pathogen of Cystic Fibrosis Patients . Journal of Bacteriology, 191(1), 261–277. http://doi.org/10.1128/JB.01230-08

• The link to the abstract from PubMed. [1]
• The link to the full text of the article in PubMedCentral. [2]
• The link to the full text of the article (HTML format) from the publisher web site. [3]
• The link to the full PDF version of the article from the publisher web site. [4]
• Who owns the rights to the article? American Society for Microbiology
  • Does the journal own the copyright? Yes
  • Do the authors own the copyright? No
  • Do the authors own the rights under a Creative Commons license? No
  • Is the article available “Open Access”? Yes
• What organization is the publisher of the article? What type of organization is it? (commercial, for-profit publisher, scientific society, respected open access organization like Public Library of Science or BioMedCentral, or predatory open access organization, see the list of) (Open Access Scholarly Publishers Association Members) here. American Society for Microbiology which is a scientific society
• Is this article available in print or online only? It is both available in print and online.
• Has LMU paid a subscription or other fee for your access to this article? Well I first looked at this article through web of science which LMU does pay for but looking at the article through PubMed, PubMed central and the publisher website was free.
• How many articles does this article cite? It has 150 cited references.
• How many articles cite this article? It is cited 128 times.
• Based on the titles and abstracts of the papers, what type of research directions have been taken now that the genome for that organism has been sequenced? A lot of the papers revolved around antibiotic resistance and therapeutic strategies.

Microarray Paper

Van Acker, H., Sass, A., Bazzini, S., De Roy, K., Udine, C., Messiaen, T., ... & Coenye, T. (2013). Biofilm-grown Burkholderia cepacia complex cells survive antibiotic treatment by avoiding production of reactive oxygen species. PLoS One, 8(3), e58943.

• This article is suitable for your project. — Kdahlquist (talk) 10:17, 10 November 2015 (PST)
• The link to the abstract from PubMed: http://www.ncbi.nlm.nih.gov/pubmed/?term=Biofilm-Grown+Burkholderia+cepacia+Complex+Cells+Survive+Antibiotic+Treatment+by+Avoiding+Production+of+Reactive+Oxygen+Species
• The link to the full text of the article in PubMedCentral: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3596321/
• The link to the full text of the article (HTML format) from the publisher web site: http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0058943
  • Cannot find HTML format on publisher web site.
• The link to the full PDF version of the article from the publisher web site: http://www.plosone.org/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0058943&representation=PDF
• Who owns the rights to the article? Authors of the article: Heleen Van Acker, Andrea Sass, Silvia Bazzini, Karen De Roy, Claudia Udine, Thomas Messiaen, Giovanna Riccardi, Nico Boon, Hans J. Nelis, Eshwar Mahenthiralingam, Tom Coenye
• Does the journal own the copyright? Yes.
• Do the authors own the copyright? No.
• Do the authors own the rights under a Creative Commons license? Yes.
• Is the article available “Open Access”? Yes.
• What organization is the publisher of the article? What type of organization is it? Public Library of Science, Professional OA Publisher, Member of Open Access Scholarly Publishers Association
• Is this article available in print or online only? Available in print and online.
• Has LMU paid a subscription or other fee for your access to this article? No.
• Where does MicroArray Data reside? https://www.ebi.ac.uk/arrayexpress/experiments/E-MEXP-3532/?keywords=&organism=Burkholderia+cenocepacia&exptype%5B%5D=%22rna+assay%22&exptype%5B%5D=%22array+assay%22&array=
• What experiment was performed? What was the "treatment" and what was the "control" in the experiment? The experiment hoped to test whether persister cells are present in Burkholderia cepacia complex (Bcc) biofilms, what the molecular basis of antimicrobial tolerance in Bcc persisters is, and how persisters can be eradicated from Bcc biofilms. Burkholderia cenocepacia biofilms were treated with 1024 µg/ml of tobramycin in the treatment group. The control group did not receive any tobramycin.
• Were replicate experiments of the "treatment" and "control" conditions conducted? Were these biological or technical replicates? How many of each? 2 technical replicates were made across 5 biological replicates for the control, and 2 technical replicates of 3 biological replicates of the treatments.
• How many articles does this article cite? This article has 34 cited references.
• How many articles cite this article? This article is cited 17 times in All Databases, and 17 time in Web of Science Core Collection.
• Based on the titles and abstracts of the papers, what type of research directions have been taken now that the genome for that organism has been sequenced? Most of the articles are related to antimicrobial therapy, tolerance, and resistance.